About Jotec
Jotec is a company based in Hechingen (Germany) founded in 2000 was acquired by CryoLife in December 2017. Jotec offers products and services including ON-X Aortic Heart Valve, AMDS Hybrid Prosthesis, and BioGlue Surgical Adhesive. Jotec operates in a competitive market with competitors including Endologix, Endoron Medical, Trivascular, Altura Medical and Aptus Endosystems, among others.
Products & Services of Jotec
Jotec offers a comprehensive portfolio of products and services, including ON-X Aortic Heart Valve, AMDS Hybrid Prosthesis, and BioGlue Surgical Adhesive.
Surgical replacement valve for aortic conditions in patients
Device for treating acute aortic dissections effectively
Adhesive for sealing tissues during cardiovascular procedures
Apps and channels of Jotec
its YouTube channel Artivion, Inc. has 11 subscribers and 30 videos.
Videos from Jotec
The most watched videos on Jotec's YouTube channel, Artivion, Inc. (11 subscribers). Click a video to play it here.
More on Artivion, Inc..
Investors in Jotec
Jotec has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include CryoLife.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biomedical services focused on aortic technologies are provided by CryoLife. | – | cryolife.com | - |
Investor details for Jotec
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Jotec
1 people are tracked at Jotec (1 in leadership).
| Name | Role | Group |
|---|---|---|
Mario Cosimetti | CEO & MD | Leadership |
Complete people profiles for Jotec
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Jotec
2 dated milestones of Jotec across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Jotec is founded.
- Exit Acquired by CryoLife.
Competitors of Jotec
Jotec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endologix, Endoron Medical, Trivascular, Altura Medical and Aptus Endosystems, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| endologix.com | 1992 | Irvine, United States | – | 488 | Minimally invasive treatments for aortic disorders are developed and manufactured. | |
| endoronmedical.com | 2019 | Kfar Saba, Israel | $15M | – | Endovascular fixation devices for cardiovascular stent grafts are manufactured. | |
| trivascular.com | 1998 | Santa Rosa, United States | $260.95M | 307 | Designs and manufactures for endovascular aortic repair equipment | |
| alturamedical.com | 2008 | Menlo Park, United States | $49.5M | – | Endovascular devices for aortic aneurysms are developed. | |
| aptusendo.com | 2002 | Sunnyvale, United States | $70M | 63 | Endograft anchoring systems for aortic aneurysms are developed. | |
| remonmedical.com | 1997 | Caesarea, Israel | $26M | – | Miniature implants are developed to monitor intra-aneurysm pressure and hemodynamics. | |
| endovastec.com | 2012 | Shanghai, China | – | – | Medical devices for treating aortic diseases are developed. | |
| nellix.com | 1994 | Palo Alto, United States | $18.2M | – | Medical device catering less invasive treatment of Abdominal Aortic Aneurysms | |
| emblok.com | 2013 | Kalamazoo, United States | $19.75M | – | Embolic protection devices are developed for TAVR procedures. |
Detailed competitors of Jotec
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Jotec
The website of Jotec (jotec.com) receives about 3.5K visits a month.
- Monthly visits3.5K
▲ 705.2% vs previous month
Websites whose visitors overlap most with Jotec. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| artivion.com | 100% | 22.8K | #1,200,184 | View details | |
| provationmedical.com | 78% | 5.7K | #3,134,212 | View details | |
medtronic.es | medtronic.es | 62% | – | – | – |
| dhzb.de | 62% | 2.7K | #6,251,887 | View details |
Latest news on Jotec
Complete news archive for Jotec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Jotec
10 companies that operate in the same segment as Jotec (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | USD 57.22 M | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Jotec
Jotec was founded in 2000.
Jotec is headquartered in Hechingen, Germany. It is registered at Hechingen, Baden-wurttemberg, Germany.
Mario Cosimetti is the current CEO of Jotec.
Founded in 2000 and based in Hechingen, Germany, Jotec operates in the medical device sector, specializing in cardiovascular solutions. Stents and surgical grafts are developed for treating aortic and peripheral vessel conditions, including abdominal and thoracic aortic diseases. CE Mark approvals have been obtained for systems such as E-vita Thoracic 3G, E-tegra, and E-ventus BX. Leadership is provided by CEO Mario Cosimetti.
Jotec's top competitors include Endologix, Trivascular and Shanghai MicroPort Endovascular MedTech.
Jotec offers ON-X Aortic Heart Valve, AMDS Hybrid Prosthesis, and BioGlue Surgical Adhesive.
Jotec has 1 investor. Key investors include CryoLife.
Jotec operates through Jotec Gmbh.
Yes. Jotec was acquired by CryoLife in December 2017.